Les meilleurs doctors en Israël pour votre Thérapie au lutétium-177 - TOP 9 des médecins

Le Prof. Merimsky dirige l'Unité d'Oncologie Orthopédique au Centre Médical Sourasky et est spécialisé dans les thérapies avancées telles que le Lutétium-177.

• Plus de 25 ans d'expérience en oncologie et dans le traitement des sarcomes
• Membre de la faculté de l'ESMO pour les sarcomes des tissus mous et des os
• Formation par fellowship à l'Institut Gustave Roussy à Paris
• Vastes publications sur les tumeurs malignes des os et des tissus mous

Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).

His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.

He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.

He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.

Expert de premier plan en thérapie au Lutétium-177 – Le Dr Raphael intègre le profilage génomique de pointe aux traitements par radionucléides ciblés au centre médical Sourasky.

• Maître de conférences et investigateur principal (PI) pour de multiples essais cliniques en oncologie
• Spécialisé dans les tumeurs thoraciques malignes et les essais cliniques de phase avancée
• Membre de l'ESMO et de l'IASLC, se concentrant sur les traitements innovants
• Responsable de l'Initiative nationale israélienne de médecine génomique en oncologie
• Enseignant exceptionnel à la faculté de médecine de l'université de Tel-Aviv

Directeur de l'hospitalisation en oncologie au Sourasky Medical Center, le Dr Stepfansky est spécialisé dans les protocoles de traitement avancés.

• Plus de 15 ans d'expérience en oncologie, y compris dans des rôles de recherche
• Chercheur principal et secondaire pour des études cliniques de phase 1 à 3
• Spécialisé en médecine interne et en oncologie
• A exercé dans des centres médicaux de premier plan en Biélorussie et en Israël

Le Dr Inna Ospovat dirige le service de thérapie nucléaire à la clinique Ichilov. Elle est spécialisée dans le Lutetium-177 PRRT – une avancée majeure dans le traitement des tumeurs neuroendocrines.

• Spécialisée en radiothérapie pour les cancers gastro-intestinaux et du poumon
• Formation en oncologie et radiothérapie à l'Hôpital universitaire Hadassah
• Membre d'ASTRO et d'ISCORT
• Fellowship à l'Hôpital universitaire PMH de Toronto

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Le professeur Rifaat Safadi dirige l'unité des maladies du foie au Centre médical Hadassah, où il est spécialisé dans les traitements de pointe tels que la thérapie au Lutétium-177.

• Plus de 30 ans d'expérience en gastro-entérologie et en hépatologie
• Formation spécialisée (Fellowship) à la Sinai School of Medicine à New York
• Membre d'associations internationales d'étude du foie
• Auteur de nombreux articles en hépatologie
• Récipiendaire de plusieurs prix scientifiques pour la recherche sur le foie